MAPS has completed the first-ever clinical trial of smoked marijuana for symptoms of post traumatic stress disorder (PTSD) in veterans of war.

MAPS is working to demonstrate the safety and efficacy of smoked botanical marijuana as a prescription medicine for specific medical uses to the satisfaction of the U.S. Food and Drug Administration.

Read from original article